August 7, 2018

Risk of Myeloid Blood Cancers are increased in relatives of patients

  The largest ever study of its type is the first to definitively show an increased risk of blood cancers in relatives of patients. A team […]
July 16, 2018
MPN patient advocacy, Nathalie Cook

MPN Patient Advocacy Works

Brilliant work by Nathalie Cook lobbying the Australian Government for access to affordable drugs for Cancer Patients Inspiring, tenacious and rewarding work that will benefit the […]
April 9, 2018
MPN research

ASH Partners with UNC, a ClinGen grantee to Curate Genomic data for Blood Research

Publisher’s Note: My source at the American Society of Hematology (ASH) informed me that “initially MPNs aren’t going to be a primary focus, however, we expect […]
March 9, 2018
MPN cells

Ruxolitinib Metformin combo: A Possible Alternative Treatment for Myeloproliferative Neoplasm Patients

Metformin demonstrates antileukemic activity and may have clinical implications for the treatment of myeloproliferative neoplasms (MPN) in combination with ruxolitinib, according to a study published in Cell Death & […]
February 22, 2018

How MPN Blood Cancers outsmart the Immune System

AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE Researchers have discovered how some of the blood cancers known as myeloproliferative neoplasms (MPNs) evade the immune system.  Their […]
February 1, 2018
clinical trial in myelofibrosis

Imago BioSciences gets FDA Approval of IND Application for Treatment of Myelofibrosis, IMG-7289 in Clinical Trials

Imago BioSciences, a clinical-stage pharmaceutical company developing novel therapies for hematological and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted their […]
Malcare WordPress Security